Clinical Trials List
Protocol NumberAV45/THK-5351
2015-08-01 - 2018-07-31
Phase II
Terminated1
ICD-10G30
Alzheimer's disease
-
Trial Applicant
-
Sponsor
-
Trial scale
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Hong-Chou Kuo Division of Neurology
- 徐隆榮 Division of Neurology
- KuoLun Huang Division of Neurology
- 吳逸民 Division of Radiology
- Tzu-Chen Yen Division of Nuclear Medicine
- Chi-Hung Liu Division of Neurology
- Kun-Ju Lin Division of Nuclear Medicine
- 張庭瑜 Division of Neurology
The Actual Total Number of Participants Enrolled
28 Terminated
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
160 participants
-
Global
0 participants
